Matches in Wikidata for { <http://www.wikidata.org/entity/Q61917464> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q61917464 description "assaig clínic" @default.
- Q61917464 description "clinical trial" @default.
- Q61917464 description "clinical trial" @default.
- Q61917464 description "clinical trial" @default.
- Q61917464 description "clinical trial" @default.
- Q61917464 description "ensaio clínico" @default.
- Q61917464 description "ensayo clínico" @default.
- Q61917464 description "ensayu clínicu" @default.
- Q61917464 description "essai clinique" @default.
- Q61917464 description "klinisch onderzoek" @default.
- Q61917464 description "клінічне випробування" @default.
- Q61917464 description "临床试验" @default.
- Q61917464 name "A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)" @default.
- Q61917464 type Item @default.
- Q61917464 label "A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)" @default.
- Q61917464 prefLabel "A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)" @default.
- Q61917464 P1132 Q61917464-F466ABF2-C7D3-42D2-9D9A-BF9DA073AEC7 @default.
- Q61917464 P1476 Q61917464-4AFE3161-F8B9-4C9A-BB85-6059FA615692 @default.
- Q61917464 P2899 Q61917464-A5A3D6F1-E365-4BBE-8755-8A762992FE19 @default.
- Q61917464 P3098 Q61917464-D6E88A52-DAF3-4F09-8B0F-5FA2AD897020 @default.
- Q61917464 P31 Q61917464-F160F950-2C10-4E3A-A202-D6F308D589DA @default.
- Q61917464 P4135 Q61917464-433089D2-D4C7-4136-AC88-D79948F8ED0F @default.
- Q61917464 P4844 Q61917464-C97C9046-D580-438E-B8E2-9731A5212BFA @default.
- Q61917464 P4844 Q61917464-E21E92C4-97AC-49D5-AC15-FAC05436F734 @default.
- Q61917464 P4844 Q61917464-F77BD0DB-125B-482B-8DDE-7EFAFACE4EE6 @default.
- Q61917464 P580 Q61917464-B9D079BB-22A4-450D-892A-728DE3060244 @default.
- Q61917464 P582 Q61917464-91169919-F393-4953-A3E5-D38F061280FE @default.
- Q61917464 P6099 Q61917464-BCCC820F-2852-4C8E-B8B4-6589BA65EB36 @default.
- Q61917464 P8005 Q61917464-8FF90D8A-2712-4038-9C44-74ED29E17E29 @default.
- Q61917464 P8363 Q61917464-7DB52CAF-EFEF-410B-AD4E-14BBBB086697 @default.
- Q61917464 P859 Q61917464-4054ED50-7725-45CB-B21E-B43A6F039118 @default.
- Q61917464 P1132 "+256" @default.
- Q61917464 P1476 "A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea" @default.
- Q61917464 P2899 "+20" @default.
- Q61917464 P3098 "NCT00496730" @default.
- Q61917464 P31 Q30612 @default.
- Q61917464 P4135 "+79" @default.
- Q61917464 P4844 Q27888052 @default.
- Q61917464 P4844 Q417997 @default.
- Q61917464 P4844 Q9635292 @default.
- Q61917464 P580 "2007-07-01T00:00:00Z" @default.
- Q61917464 P582 "2008-08-01T00:00:00Z" @default.
- Q61917464 P6099 Q42824827 @default.
- Q61917464 P8005 Q76651189 @default.
- Q61917464 P8363 Q78089383 @default.
- Q61917464 P859 Q58219685 @default.